Clinical trials: Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy, open to volunteers
- Condition Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
- Status Open to volunteers
Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
The purpose of this study is to evaluate the efficacy and safety of SMZ1 tablets in combination with Ranibizumab compared with placebo in combination with Ranibizumab in subjects with neovascular (wet) age-related macular…
- Trial name
- NCT07695207
- Testing
- SMZ1
- Where
- South Korea
- Volunteers
- 266 people
- Sponsor
- SANGMYUNG innovation